Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v8-EN
Language French English
Date Updated 2023-01-30 2022-09-08
Drug Identification Number 01901915 01901915
Brand name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients EPINEPHRINE LIDOCAINE HYDROCHLORIDE EPINEPHRINE LIDOCAINE HYDROCHLORIDE
Strength(s) 0.01MG 20MG 0.01MG 20MG
Dosage form(s) SOLUTION SOLUTION SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 25 x 20mL vial 25 x 20mL vial
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-07-27 2022-07-27
Estimated end date 2022-12-30
Actual end date 2023-01-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments